For years, Escherichia coli and wheat germ extracts—thanks to their high protein yields—have been considered “go-to” systems for producing recombinant proteins. They, however, often lack the ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Regeneron's monoclonal antibody treatment was a focus of discussion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results